Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT03958084 Not yet recruiting - Healthy Clinical Trials

Effect of Therapeutic Techniques on Leg Stretching in Healthy Subjects

Start date: July 20, 2020
Phase: N/A
Study type: Interventional

There are physiotherapy techniques, known as lumbar mobilization, proprioceptive neuromuscular facilitation, massage therapy, windsheets and foam roller that present good results in stretching the legs. This study aims to evaluate which of these techniques has a better result in leg stretching. It is believed that massage therapy and lumbar mobilization will provide better results.

NCT ID: NCT03937648 Not yet recruiting - Healthy Clinical Trials

Study to Evaluate Pharmacokinetics, Safety, and Tolerability Ildong COL-144 Tablet in Korean Healthy Volunteers

Start date: August 1, 2019
Phase: Phase 1
Study type: Interventional

A Randomized, Double blind, Placebo-controlled, Single-dose, Dose-escalation Study to Evaluate Pharmacokinetics, Safety, and Tolerability with Oral Administration of Ildong COL-144 tablet in Korean Healthy Volunteers

NCT ID: NCT03907020 Not yet recruiting - Healthy Clinical Trials

Metabolic Availability of Lysine From Barley in Young Adult Men

Start date: August 2025
Phase: N/A
Study type: Interventional

Protein is the key determinant of growth and bodily functions. The quality of food proteins depend on their amino acid content and the amount of amino acids used by the body to make proteins. Globally Cereal Grains (CG) provide 50% of the calories and protein in the diet and exceed 80% in poorer developing countries. Barley is an important cereal grain in the diet. The protein in barley is low in the essential amino acid lysine. Hence barley protein is of low quality. Low lysine affects protein synthesis in the body. Cooking methods also affect the lysine available from foods to the body. It is important to assess the effect of different cooking methods on the lysine availability of barley.

NCT ID: NCT03895567 Not yet recruiting - Healthy Clinical Trials

Study to Compare Blood Levels of Ceftriaxone Given by Suppository or Injection.

CefREC
Start date: June 2024
Phase: Phase 1
Study type: Interventional

Phase 1, three-way cross-over, randomised, open label comparison of intravenous versus two rectal dosage forms of ceftriaxone in 37 healthy Thai adults. The following regimens will be evaluated in random order in all participants: A. Ceftriaxone (Roche ®) 500mg (slow intravenous injection) B. Ceftriaxone rectal dosage form test formulation 1-hard-shell gelatin capsule (1 x 500mg) C. Ceftriaxone rectal dosage form test formulation 2-rectodispersible mannitol-based tablet (1 x 500mg) Possible schedules: ABC, ACB, BAC, BCA, CAB, CBA. Each recipient will receive a single treatment dose of each of the three formulations in an order predetermined by a computer generated randomisation list. This will be a constrained randomization which ensures approximately balanced proportions for all six schedules (either 6 or 7 participants per schedule). There will be 7-28 days washout period between doses. The last follow up visit is 28 (+ 2) days after final dose. Participants lost to follow-up or unevaluable for any reason before completion of pharmacokinetic sampling after the final dose will be replaced at the discretion of the investigators with another participant of the same population, if either sample size or completeness of dataset is compromised. This study is funded by the Medical Research Council. The grant reference number is MR/W021560/1

NCT ID: NCT03826485 Not yet recruiting - Healthy Clinical Trials

Safety, Pharmacokinetic Study of PRIC in Healthy Adult Subjects

Start date: April 1, 2019
Phase: Phase 1
Study type: Interventional

The purpose of this study is Safety, Pharmacokinetic Study of PRIC

NCT ID: NCT03791957 Not yet recruiting - Healthy Clinical Trials

The Association of Blood Haemoglobin and Colour of Gums

Start date: December 20, 2019
Phase:
Study type: Observational [Patient Registry]

AIM: To evaluate the association of the levels of blood haemoglobin to the distribution and severity of gingival melanin pigmentation at 3 different periodontal health status SAMPLE SIZE ESTIMATION - Done using GPower v.3.1.9.2 - Total sample size = 60 (20 each in 3 groups) - Effect size = 40% - Power = 80% - α-error = 5% SAMPLING: - Simple random sampling - Subjects to be recruited from out patient pool of KLE Society's Institute of Dental Sciences, Bangalore - Subjects to be categorised into 3 groups (20 subjects each) 1. Group A - Healthy periodontium 2. Group B - Gingivitis 3. Group C - Periodontitis PARAMETERS ASSESSED - Blood Haemoglobin Concentration (in %gm/dL) - Hedin Melanin Index Score 0: No pigmentation Score 1: one or two solitary unit(s) of pigmentation in papillary gingiva without formation of a continuous ribbon between solitary units Score 2: More than three units of pigmentation in papillary gingiva without the formation of a continuous ribbons of pigmentation Score 3: One or more short continuous ribbons of pigmentation Score 4: One continuous ribbon including the entire area between canines STATISTICAL ANALYSIS - SPSS for Windows Version 22.0 to be used - Descriptive statistics: It includes expression of study parameters in terms of Mean & SD for continuous variables, whereas in terms of frequency and proportions for categorical variables. - Inferential Statistics: Chi Square Test will be used to compare the pigmentation index between 03 groups. And similarly, gender wise comparison of hemoglobin concentration will be done using the same test. One-way ANOVA test followed by Tukey's HSD post hoc Analysis will be used to compare the mean hemoglobin levels based on the pigmentation index scores in each group. The level of significance [P-Value] was set at P<0.05

NCT ID: NCT03762837 Not yet recruiting - Healthy Clinical Trials

Multicenter Prospective Cohort Study of Risk Factors for Gallbladder Cancer

Start date: April 1, 2019
Phase:
Study type: Observational [Patient Registry]

This trial is a prospective study, the main purpose of the study is to investigate the association between benign gallbladder disease and gallbladder carcinoma; to explain the timing of intervention, intervention and early prevention of benign gallbladder disease; according to the national epidemiology of gallbladder cancer Center Clinical Research (unpublished), 2000 National Cholecystoma Clinical Epidemiology Report, and 2005 Clinical Analysis of 2379 Cases of Gallbladder Carcinoma in 17 Hospitals in Five Northwest Provinces, Pre-experimental data, using samples The volume estimation formula, α = 0.05, β = 0.1, plans to enroll 100,000 people.Half of participants is someone with Biliary benign disease,while the other half is healthy.

NCT ID: NCT03748407 Not yet recruiting - Healthy Clinical Trials

Determination of Baseline Thyroid Status Values in French Adult Population

THYRBECK
Start date: November 30, 2018
Phase: N/A
Study type: Interventional

The objective of this study is to establish reference values in the general population from a Beckman Coulter DxI chemiluminescence assay. Indeed, the lack of harmonization of the methods of the dosage remains a major difficulty to optimize the management of patients with thyroid disease. This supplier has recently optimized its dosing kit according to the 3rd international standard of the WHO (IRB 81/565) for the TSH (Thyroid Stimulating Hormon). It is necessary to carry out a study of the distribution of the values of this TSH within our metropolitan population. The current data proposed by the supplier come from a study of a North American population. investigators propose to define usual values for thyroid status markers (TSH, FT4 [free thyroxine], FT3 [free triiodothyroxine]) from healthy EFS (French Blood Establishment) donors who meet the standard exclusion criteria for this type of study.

NCT ID: NCT03632408 Not yet recruiting - Healthy Clinical Trials

Hangover and Residual Zopiclone Effect on Spatial Perception

SEKO-A
Start date: September 2018
Phase: Phase 1
Study type: Interventional

Hangover after recreational alcohol use, residual effect of zopiclone and placebo compared in terms of spatial perception, psychomotor tests and simulated driving ability. Three recording visits plus screening included.

NCT ID: NCT03599466 Not yet recruiting - Healthy Clinical Trials

Clinical Bioequivalence Study on Two Lisinopril Tablets 20mg Formulations

Start date: October 2019
Phase: Phase 1
Study type: Interventional

The objective of the study is to compare the bioavailability of a generic product of lisinopril with that of a reference product when administered to healthy volunteers under fasting condition. The test product is BF-Lisinopril Tablet 20mg (HK-63564) manufactured by Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited, and the reference product is Zestril Tab 20mg (HK-30515). The bioequivalence or bioinequivalence of the test and reference formulations will be assessed and concluded based on the plasma pharmacokinetic data of lisinopril, as well as WHO guidelines on registration requirements to establish interchangeability.